HST Global Inc. EBITDA

EBITDA of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA growth rates and interactive chart. Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in depreciation, interest expenses (debt), writedowns or other accounting measures and taxes. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment. To calculate EBITDA, take operating profit (also called EBIT) and add back depreciation and amortization.


Highlights and Quick Summary

  • EBITDA for the quarter ending June 29, 2020 was $-43.8 Thousand (a 25.86% increase compared to previous quarter)
  • Year-over-year quarterly EBITDA decreased by -20.36%
  • Annual EBITDA for 2019 was $-152 Thousand (a 6.31% increase from previous year)
  • Annual EBITDA for 2018 was $-143 Thousand (a -6.8% decrease from previous year)
  • Annual EBITDA for 2017 was $-153 Thousand (a 11.43% increase from previous year)
  • Twelve month EBITDA ending June 29, 2020 was $-159 Thousand (a 6.0% increase compared to previous quarter)
  • Twelve month trailing EBITDA decreased by -1.0% year-over-year
Trailing EBITDA for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-159 Thousand $-150 Thousand $-152 Thousand $-161 Thousand
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA of HST Global Inc.

Most recent EBITDAof HSTC including historical data for past 10 years.

Interactive Chart of EBITDA of HST Global Inc.

HST Global Inc. EBITDA for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.04 $-0.03
2019 $-0.03 $-0.06 $-0.03 $-0.04 $-0.15
2018 $-0.03 $-0.03 $-0.04 $-0.04 $-0.14
2017 $-0.03 $-0.03 $-0.03 $-0.05 $-0.15
2016 $-0.03 $-0.03 $-0.04 $-0.03 $-0.14
2015 $-0.04 $-0.03 $-0.04 $-0.05 $-0.16
2014 $-0.04 $-0.04 $-0.04 $-0.04 $-0.15
2013 $-0.03 $-0.04 $-0.06 $-0.03 $-0.16
2012 $-0.08 $-0.08 $-0.1 $-0.08 $-0.34
2011 $-0.25 $-0.08 $-0.1 $-0.09 $-0.5
2010 $-0.08 $-0.15 $-0.31 $-0.21 $-0.75
2009 $-0.66 $-1.32

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.